Your browser doesn't support javascript.
loading
DLL3 promotes progression of prostate cancer through MAPK pathway / 中国病理生理杂志
Chinese Journal of Pathophysiology ; (12): 2165-2175, 2023.
Article de Zh | WPRIM | ID: wpr-1023825
Bibliothèque responsable: WPRO
ABSTRACT
AIM:To explore the impact of Delta-like ligand 3(DLL3)on the progression of prostate cancer(Pca)and to elucidate its potential molecular mechanisms.METHODS:Overexpression and interference plasmids of DLL3 gene were constructed,and the effects of DLL3 on the proliferation,migration and invasion of Pca cells were as-sessed.Tumorigenesis assay was employed to determine whether DLL3 influenced the proliferation of PC-3 cells in vivo.The impact of DLL3 on epithelial-mesenchymal transition(EMT)and mitogen-activated protein kinase(MAPK)signaling was investigated through Western blotting.RESULTS:Overexpression of DLL3 significantly enhanced the proliferation,migration,invasion and EMT processes of Pca cells compared with empty vector group and blank control group(P<0.05).Conversely,knockdown of DLL3 expression yielded opposite effects(P<0.05).Moreover,up-regulation of DLL3 promoted tumor growth in the nude mouse xenograft model(P<0.05).Further investigation demonstrated that DLL3 up-regulation led to increases in the levels of MAPK signaling pathway-related proteins.Interestingly,MAPK inhibitor effec-tively reduced the proliferation,migration and invasion of Pca cells caused by DLL3 overexpression(P<0.05).CON-CLUSION:DLL3 promotes the proliferation,migration and invasion of Pca through the MAPK pathway.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Chinese Journal of Pathophysiology Année: 2023 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Chinese Journal of Pathophysiology Année: 2023 Type: Article